A Pilot Study to Understand the Adolescent Pain Experience During Contraceptive Implant Insertion.
S D Bentsianov, K Brandi, P Chen...
https://pubmed.ncbi.nlm.nih.gov/33515699/Actively Recruiting
Led by Queen's Medical Center · Updated on 2026-10-13
70
Participants Needed
3
Research Sites
17 weeks
Total Duration
This research investigates whether Pain Ease vapocoolant spray can reduce the pain caused by lidocaine injections during Nexplanon implant insertion in the arm. The study focuses on patients undergoing this procedure and aims to compare the effects of the vapocoolant spray against a placebo spray. It is a randomized controlled trial designed to evaluate pain relief during a common contraceptive implant procedure. Participants are randomly assigned to receive either the Pain Ease vapocoolant spray or a placebo saline spray called Natures Tears on their arm just before the lidocaine injection. The Pain Ease spray is applied according to manufacturer instructions for up to 5 seconds or until the skin turns white. Both sprays are administered immediately prior to the local anesthetic injection during the Nexplanon insertion procedure. The study uses a single-blind design, meaning patients do not know which spray they receive. During the study, participants undergo the Nexplanon insertion with the assigned spray applied before the lidocaine injection. Researchers assess pain immediately after the lidocaine injection and after the full procedure, along with patient satisfaction. The trial involves evaluation of pain and comfort related to the sprays during the insertion process. All procedures and assessments occur during the office visit, with no extended follow-up periods mentioned.
CONDITIONS
Vapocoolant Spray to Reduce Pain With Nexplanon Insertion
S
Sarah Murayama, MD
M
Mary Tschann, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Queen's Medical Center
Lead Sponsor
Lakshmi Devi and Devraj Sharma Endowment
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Vapocoolant spray | Placebo spray | Topical lidocaine spray |
|---|---|---|---|
| What it is | A device‑based spray applying cold over the implant site for 5 seconds or until skin whitening, per manufacturer instructions | A placebo spray (Nature’s Tears) applied to the arm as a control procedure | Topical lidocaine spray used in clinical practice for pain relief during in‑office gynecologic procedures |
| Role in trial | Investigational intervention being evaluated for reducing pain | Placebo control used for comparison | Example of a standard topical anesthetic procedure not part of this trial |
| Primary use | To reduce pain during etonogestrel implant insertion | Control spray to measure placebo effect on pain | To numb the skin and reduce pain during similar minor procedures |
| How it is given or performed | Spray applied for up to 5 seconds or until skin turns white, as instructed by manufacturer | Placebo spray applied to the same arm location | Topical lidocaine spray is applied to numb skin before minor procedures |
| Evidence status | Effectiveness for Nexplanon insertion pain is under investigation in this randomized trial | Serves as control; no expectation of analgesic benefit | Topical lidocaine has demonstrated pain reduction in procedures like IUD insertion in clinical practice |
| Important risks | Potential skin cooling-related discomfort or transient blanching; safety monitoring ongoing | Minimal known risk beyond any spray application | Low risk when used as recommended, though local irritation possible |
| Important limitations | Limited evidence; applicability to this specific procedure unknown until results available | Placebo does not reflect standard-of-care analgesia | Effectiveness shown in other procedures but not specifically evaluated for Nexplanon insertion |
| Patient impact | Unknown until trial results; investigational | No expected impact beyond placebo effect | Patients often report less pain with lidocaine spray in minor office procedures |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single office visit
Participants receive either the Pain Ease vapocoolant spray or a placebo spray applied on the arm just before the lidocaine injection during the Nexplanon implant insertion procedure.
During Nexplanon insertion appointment
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
S D Bentsianov, K Brandi, P Chen...
https://pubmed.ncbi.nlm.nih.gov/33515699/G Anthony Wilson, Julie W Jeter, William S Dabbs...
https://pubmed.ncbi.nlm.nih.gov/32123573/Yun Zhu, Xue Peng, Shuang Wang...
https://pubmed.ncbi.nlm.nih.gov/30253890/Sharon E Mace
https://pubmed.ncbi.nlm.nih.gov/26979261/Nursemin Unal, Betul Tosun, Ozlem Aslan...
https://pubmed.ncbi.nlm.nih.gov/30698458/K H Todd, K G Funk, J P Funk...
https://pubmed.ncbi.nlm.nih.gov/8604867/F Collado-Mesa, J M Net, K Arheart...
https://pubmed.ncbi.nlm.nih.gov/26162573/Queen's Medical Center
Lead Sponsor
Lakshmi Devi and Devraj Sharma Endowment
Collaborating Sponsor